A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors

Clinical Trial ID NCT00721669

PubWeight™ 2.66‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00721669

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Emerging targeted agents in metastatic breast cancer. Nat Rev Clin Oncol 2013 1.59
2 Therapeutic targets for bone metastases in breast cancer. Breast Cancer Res 2011 1.16
Next 100